FDA Flags J&J For Inadequate Oversight Of Consumer Devices
This article was originally published in The Rose Sheet
Executive Summary
Though the firm claims to have come a long way in improving management of OTC pharma quality control since its 2009/2010 recalls, a May 22 warning letter regarding post-market monitoring and pre-market notifications for K-Y moisturizers suggests consumer devices are not getting the same level of attention.